|
HHS Border Health Intra-agency Working Group
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, CDC, FDA, HRSA, IHS, OS
|
NICHD, NIA, NIAID, NIDDK, NIMH, NIMHD
|
This intra-agency workgroup allows for the exchange of information and cooperation among HHS agencies on issues related to border health. The purpose of this group is to convene HHS components that have a vested interest in US-Mexico border health issues to provide a platform for discussion, coordinate efforts, and potentially identify mutual areas of collaboration to improve the health and quality of life for border residents.
|
|
HHS Data Council
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, CDC, CMS, HRSA, IHS, OS, SAMHSA
|
OD/DPCPSI/OBSSR
|
Coordinates all health and human services data collection and analysis activities of the Department of Health and Human Services, including an integrated data collection strategy, coordination of health data standards and health and human services and privacy policy activities.
|
|
HHS Dietary Guidance Review Committee
|
Committee, Work group, Advisory group, or Task Force
|
ACF, CDC, FDA, HRSA, IHS, OS
|
NIDDK
|
This committee reviews draft nutrition materials developed by all federal agencies and fulfills the legislative mandate (1990 NNMRRA) to ensure that Federal dietary guidance is consistent with the Dietary Guidelines for Americans and is scientifically accurate.
|
|
HHS ED Developmental and Behavioral Screening Working Group
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, CDC, CMS, HRSA, SAMHSA
|
NICHD
|
This committee supports the objectives of improving developmental and behavior screening.
|
|
HHS Environmental Justice Working Group
|
Public Education Campaign
|
CDC, FDA, HRSA, OS, SAMHSA
|
NIEHS, NIMHD
|
The Office of the Assistant Secretary for Health (OASH) is responsible for coordinating interdisciplinary programs within HHS and ensures that HHS works in concert with its federal partners, including the Environmental Justice Working Group. OASH staff lead the HHS Environmental Justice Working Group with bi-weekly meetings that provide time for sharing information and new approaches, identifying opportunities for collaboration, and updating progress toward advancing the actions of the 2012 HHS Environmental Justice Strategy and the Priority Areas of Focus. HHS EJ Working Group members are responsible for coordinating and reporting on activities related to environmental justice within their agencies.
|
|
HHS Evidence & Evaluation Policy Council
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
OD/OSP
|
The HHS Evidence & Evaluation Policy Council was instituted in 2016. The aims of the Council are to develop and coordinate a community within HHS that can advise and consult with their agencies on evaluation and evidence activities. The council works toward improving efficiency and effectiveness in planning, conducting, and disseminating evaluations and evidence throughout HHS, and ensuring the integrity, rigor, and relevance of the information collected, analyzed, and disseminated for evaluation purposes. Activities focus on coordination and collaboration, emphasizing areas of common interest. Example topics include staff development, emerging issues like using administrative data for evaluation purposes, working effectively with leadership and agency partners, and adopting common principles and practices.
|
|
HHS Global Health Collaborative
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIMH
|
This interagency working group meets to provide a forum within the Department of Health and Human Services (HHS) that identifies Global Health issues relevant to the HHS Global mental health agenda.
|
|
HHS Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NICHD, NIAID, OD/DPCPSI/OAR
|
These guidelines were prepared by the Opportunistic Infections Working Group under the auspices of the Office of AIDS Research Advisory Council (OARAC) of the NIH. Briefly, six co-editors selected and appointed by their respective agencies (i.e., NIH, CDC, IDSA) convened working groups of clinicians and scientists with subject matter expertise in specific HIV-associated opportunistic infections. The co-editors appointed a leader for each working group, which reviewed the literature since the last publication of these guidelines, conferred over a period of several months, and produced draft revised recommendations. Issues requiring specific attention were reviewed and discussed by the co-editors and the leaders from each working group at the annual meeting of the IDSA in Vancouver, Canada, in October 2010. After further revision, the guidelines were reviewed by patient care advocates and by primary care providers with extensive experience in the management of HIV infection.
|
|
HHS H5N1 Gain-of-Function Review Group (HHG Review Group)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
OD/OSP, NIAID
|
The Framework for Guiding HHS Funding Decisions about Research Proposals with the Potential for Generating Highly Pathogenic Avian Influenza (HPAI) H5N1 Viruses that are Transmissible among Mammals by Respiratory Droplets requires that certain research proposals undergo additional review at both the funding agency and Departmental (HHS) levels prior to funding. The HHS Department-level review is performed by the HHG Review Group, which brings to bear multidisciplinary interagency expertise in science, countermeasure development and availability, national security, law, public health preparedness and response, biodefense, select agent regulations, and science and public health policy. The purpose of the HHS Department-level review includes review of the funding agency''s risk assessment, consideration of whether additional factors may alter assessment of whether the research can be funded, determination of which measures are needed to mitigate risks, consideration of the overall HHS influenza research portfolio, and determination of whether the proposal is acceptable for HHS funding.
|
|
HHS Health Disparities Council
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, OS, SAMHSA
|
NIMHD
|
The HHS Health Disparities Council serves as the venue to share information, leverage HHS investments, coordinate HHS activities, reduce program duplication, and track progress on the strategies and actions of the HHS Disparities Action Plan.
|